GeneFerm Biotechnology Co., Ltd. (TPEX:1796)
Taiwan
· Delayed Price · Currency is TWD 40.00
-1.60 (-3.85%)
Mar 9, 2026, 1:30 PM CST
GeneFerm Biotechnology Market Cap
GeneFerm Biotechnology has a market cap or net worth of 1.66 billion as of March 9, 2026. Its market cap has decreased by -6.54% in one year.
Market Cap
1.66B
Enterprise Value
1.70B
Revenue
677.10M
Ranking
n/a
PE Ratio
57.14
Stock Price
40.00
Market Cap Chart
Since July 26, 2016, GeneFerm Biotechnology's market cap has decreased from 2.17B to 1.66B, a decrease of -23.72%. That is a compound annual growth rate of -2.77%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tien Liang BioTech | 1.65B |
| InnoPharmax | 1.65B |
| TSH Biopharm Corporation | 2.00B |
| Winston Medical Supply | 1.48B |
| DV Biomed | 1.34B |
| Golden Biotechnology | 2.26B |
| Excelsior Biopharma | 1.26B |
| Johnson Chemical Pharmaceutical Works | 2.54B |